Prener Anne
Reporting owner on Forms 3, 4 and 5, CIK 1797917.
Prener Anne reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| KROS · Keros Therapeutics, Inc.CIK 1664710 | director | 2 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| KROS · Keros Therapeutics, Inc.Common Stock | 2026-11-17 | S sold | -433 | $10.77 | 12,779 | Form 4 |
| KROS · Keros Therapeutics, Inc.Common Stock | 2026-11-17 | S sold | -142 | $11.03 | 12,637 | Form 4 |
| KROS · Keros Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -574 | $9.79 | 13,212 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001797917-26-000011 | Keros Therapeutics, Inc. | 2026-11-19 | ||
| Form 4 0001797917-26-000009 | Keros Therapeutics, Inc. | 2026-11-16 |